Glucose Health Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Glucose Health's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Personal Products Industry Growth20.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2022

Recent past performance updates

No updates

Recent updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Glucose Health has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown
Beta

How Glucose Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:GLUC Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 221000
30 Jun 221010
31 Mar 221-110
31 Dec 211000
31 Dec 200000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150-100
30 Jun 150-110
31 Mar 150-110
31 Dec 140-110
30 Sep 140-110
30 Jun 140-110
31 Mar 140-110
31 Dec 130-110
30 Sep 130-110

Quality Earnings: Insufficient data to determine if GLUC has high quality earnings.

Growing Profit Margin: Insufficient data to determine if GLUC's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if GLUC's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare GLUC's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if GLUC's earnings growth over the past year exceeded the Personal Products industry average.


Return on Equity

High ROE: GLUC has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.